Navigation Links
NeurogesX to Provide Qutenza® Launch Update
Date:2/9/2011

SAN MATEO, Calif., Feb. 9, 2011 /PRNewswire/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced it will hold a conference call on February 14, 2011 at 4:30 p.m. ET (1:30 p.m. PT) to provide an update on the U.S. commercial launch of Qutenza® (capsaicin) 8% patch for the management of neuropathic pain associated with postherpetic neuralgia (PHN).

NeurogesX will highlight key metrics for tracking U.S. physician adoption during the three month period ended December 31, 2010, approximately one month prior to filing fourth quarter 2010 financial results.

The conference call will be hosted by Anthony DiTonno, President and Chief Executive Officer, and Stephen Ghiglieri, Executive Vice President, Chief Operating Officer and Chief Financial Officer.

To participate, please dial 1-877-407-0789 (USA) or 1-201-689-8562 (International).  To access the live web cast please visit the Investor Relations section on the corporate web site at http://www.neurogesx.com.

A replay of the conference call will be available beginning February 14, 2011 at 8:00 p.m. ET (5:00 p.m. PT) and ending on February 24, 2011 by dialing 1-877-870-5176 (USA) or 1-858-384-5517 (International) with Conference ID Number: 367175.  A replay of the webcast will also be available on the corporate website through March 14, 2011.

The call will be webcast live and archived for 90 days on the investor relations section of NeurogesX' website at www.neurogesx.com.

About NeurogesX, Inc.

NeurogesX, Inc. (Nasdaq: NGSX) is a San Francisco Bay Area-based biopharmaceutical company focused on developing and co
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NeurogesX to Present at Two February Investor Conferences
2. NeurogesX Receives Qutenza®-Specific J-Code From Centers for Medicare and Medicaid Services (CMS)
3. NeurogesX Doses First Patient in Phase 2 Clinical Study of NGX-1998 Liquid Capsaicin Formulation
4. NeurogesX to Hold Conference Call to Discuss Third Quarter 2010 Results
5. NeurogesX to Present at Oppenheimer & Co Healthcare Conference
6. Although NeurogesX/Astellass Qutenza is Only Approved for Postherpetic Neuralgia, Surveyed U.S. Physicians are Likely to Prescribe It for All Neuropathic Pain Types
7. NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director
8. NeurogesX Receives FDA Approval of Qutenza(TM) (capsaicin) 8% Patch for Treatment of Postherpetic Neuralgia (PHN)
9. NeurogesX Expands Commercial Operations Leadership Team
10. NeurogesX to Hold Conference Call to Discuss Third Quarter 2009 Financial Results
11. NeurogesX to Present at JMP Securities Healthcare Focus Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/17/2014)... , November 17, 2014 ... Boston on 20 November   ... discovery and development company, is pleased to announce that ... as one of ten top projects in neuroscience by ... Grau will present an overview of the programme ...
(Date:11/16/2014)... , November 17, 2014 ... Medicine Index 2014 hebben de top-20 farmaceutische ... om de toegang tot medicijnen in ontwikkelingslanden te ... innovaties. Maar op een aantal punten blijven de ... ) , GSK voert de ...
(Date:11/16/2014)... The world,s leading pharmaceutical companies are doing ... with a raft of new initiatives, scale-ups and innovations ... to perform well in some practices that matter, according ...      (Photo: http://photos.prnewswire.com/prnh/20141116/717224-INFO ) , ... time. This is driven by robust performance across most ...
Breaking Medicine Technology:Heptares First-in-Class Selective Muscarinic Agonists Chosen as one of top Neuroscience Projects to Watch 2Farmaceutische industrie doet meer om toegang tot medicijnen in ontwikkelingslanden te verbeteren; op een aantal punten blijven prestaties achter 2Farmaceutische industrie doet meer om toegang tot medicijnen in ontwikkelingslanden te verbeteren; op een aantal punten blijven prestaties achter 3Farmaceutische industrie doet meer om toegang tot medicijnen in ontwikkelingslanden te verbeteren; op een aantal punten blijven prestaties achter 4Pharmaceutical Industry Doing More to Improve Access to Medicine in Developing Countries; Performance on Some Aspects Lags 2Pharmaceutical Industry Doing More to Improve Access to Medicine in Developing Countries; Performance on Some Aspects Lags 3Pharmaceutical Industry Doing More to Improve Access to Medicine in Developing Countries; Performance on Some Aspects Lags 4
... Inc. announced today that, with a 23-month ... randomized, double-blind, placebo-controlled, phase 2 study of exemestane ... locally recurrent or metastatic estrogen receptor-positive breast cancer, ... patients reached 26.9 months versus 19.8 months for ...
... PARK, Calif., Dec. 7, 2011 Jia-Hwa Fang, ... of Clinical Manufacturing.  In this new role, he ... R&D, Good Laboratory Practice (GLP), and pilot formulations ... with Good Manufacturing Practices (GMP).  He will be ...
Cached Medicine Technology:Survival Benefit With Syndax Pharmaceuticals' Entinostat Maintained in Women with Advanced Breast Cancer 2Survival Benefit With Syndax Pharmaceuticals' Entinostat Maintained in Women with Advanced Breast Cancer 3Survival Benefit With Syndax Pharmaceuticals' Entinostat Maintained in Women with Advanced Breast Cancer 4Jia-Hwa Fang Joins SRI Biosciences as Director of Clinical Manufacturing 2
(Date:11/18/2014)... Scottsdale, AZ (PRWEB) November 18, 2014 ... leader in medical information, risk management and investigative ... 5 Star Examiner Performance Model to enhance its ... their distribution partners. Through use of EMSI’s ... confident in knowing that their paramedical exams are ...
(Date:11/18/2014)... Steven Reinberg HealthDay Reporter ... with the abnormal heartbeat known as atrial fibrillation who ... bleeding and blood clots, according to a new study. ... took a blood thinner along with one of these ... (Motrin), naproxen (Aleve) and celecoxib (Celebrex). "If ...
(Date:11/18/2014)... who started smoking at a young age may be ... new study suggests. About 29 percent of women ... as a risk factor for severe menstrual pain, the ... study said. The researchers analyzed data from 9,000 ... health in Australia. About 14 percent of the women ...
(Date:11/18/2014)... 18, 2014 OpenWorks, one of America’s ... the 2014 Lincoln Guild Invitational. The John C. Lincoln ... support the Phoenix-area Desert Mission community programs. Open Works ... The tournament was held at Camelback Golf Club in ... the efforts of Desert Mission — including a food ...
(Date:11/18/2014)... Sorrel Sky Gallery welcomes jewelry artist ... of her beautiful, one-of-a-kind pieces. Just in time for the ... gallery, Friday, December 5 from 5 – 7:30 p.m. for ... artistic creations began at her grandmother’s kitchen table at a ... designs. She studied at the Gemological Institute of America in ...
Breaking Medicine News(10 mins):Health News:EMSI Launches Proprietary 5 Star Examiner Performance Model to Enhance Paramedical Exam Service 2Health News:Some Painkillers Tied to Bleeding Risk in Those With Abnormal Heartbeat 2Health News:Study Ties Teen Smoking to Risk of Severe Menstrual Cramps 2Health News:OpenWorks Sponsors 2014 Lincoln Guild Invitational Golf Tournament Hosted by Scottsdale's Camelback Golf Club 2Health News:Elizabeth Showers Trunk Show & Personal Appearance Hosted by Sorrel Sky Gallery 2
... ... available at ShopCompex.com , ... Diego, CA (PRWEB) November 9, 2009 -- Compex®, a brand of DJO Incorporated, a global ... electrical muscle stimulation unit – the Compex Sport Elite. The Sport Elite was designed ...
... ... clothing drive for November , ... Surrey, BC (Vocus) November 9, 2009 -- The students and staff at Vancouver Career College ... citizens to do the same in order to help women and children in need., , ...
... In the wake of the Fort Hood tragedy, Give an ... health professionals in Texas to join the Give an Hour(TM) ... providing free counseling and other mental health services to active ... forces, and veterans of Iraq and Afghanistan who have separated ...
... Centers for Disease Control and Prevention (CDC) recently awarded the ... three years to continue funding its National Sexual Violence Resource ... since 2000 to serve as the nation,s principle center for ... forms of sexual violence and its prevention. , ...
... Family Solutions® today announced that it has been named the ... The prestigious ranking on the Globe 100,s Top Places to ... to support its employees and despite the downturn in the economy, ... where employees feel valued and supported at both work and home. ...
... Proust,s Madeleines to the overbearing food critic in the movie ... of stew, artists have long been aware that some odors ... of Science have now revealed the scientific basis of this ... Current Biology . Graduate student Yaara Yeshurun, together ...
Cached Medicine News:Health News:COMPEX Intoduces New Sport Elite Electrical Muscle Stimulation Unit 2Health News:COMPEX Intoduces New Sport Elite Electrical Muscle Stimulation Unit 3Health News:Surrey College Students Collect Clothing for Women and Children 2Health News:Give an Hour(TM) Partners with American Red Cross and Calls All Mental Health Professionals in Texas to Volunteer Their Services 2Health News:CDC Awards Vital Prevention Funding to National Sexual Violence Resource Center 2Health News:Bright Horizons Named One of Boston Globe 100's Top Places to Work 2Health News:Sniffing out memories 2
... Shielding's new Breast ... designed to provide extra ... area. The adjustable velcro ... quick, comfortable fit, plust ...
Lap pad used to protect pelvic regions...
... necessary, the Two-Piece should be your ... comfort through more efficient distribution of ... vest comes with shoulder pads and ... well as an attached belt to ...
Fluoro done? Get rid of your apron quickly and easily without breaking the sterile field. Shoulder pads and hanging straps are standard....
Medicine Products: